Proton Pump Inhibitors; Gastroesophageal Reflux Disease; Esophagitis;


Deprescribing Proton Pump Inhibitors

Canadian professional groups recommended deprescribing proton pump inhibitors (PPIs) in adults who have completed a minimum of 4 weeks of PPI treatment for heartburn or mild to moderate gastroesophageal reflux disease or esophagitis, and whose symptoms are resolved. Deprescirbing by decreasing the daily dose or stopping and changing to on-demand […]